ObjectiveCortical atrophy has been associated with late-life depression (LLD) and recent findings suggest that reduced right hemisphere cortical thickness is associated with familial risk for major depressive disorder, but cortical thickness abnormalities in LLD have not been explored. Furthermore, cortical atrophy has been posited as a contributor to poor antidepressant treatment response in LLD, but the impact of cortical thickness on psychotherapy response is unknown. This study was conducted to evaluate patterns of cortical thickness in LLD and in relation to psychotherapy treatment outcomes.MethodsParticipants included 22 individuals with LLD and 12 age-matched comparison subjects. LLD participants completed 12 weeks of psychotherapy a...
Major depressive disorder (MDD) is accompanied by atypical brain structure. This study first present...
Major depression is a prevalent disease among the elderly, significantly decreasing the quality of l...
Late-life depression (LLD) is a growing public and global health concern with diverse clinical manif...
Background: Reduced cortical thickness is a candidate biological marker of depression, although findi...
The brain disturbances that place a person at risk for developing depression are unknown. We imaged ...
OBJECTIVE Impaired mood regulation is a key deficit of major depressive disorder that is primarily m...
BACKGROUND: Late life depression is associated with volumetric reductions of gray matter and increas...
Background: Reduced cortical thickness and hippocampal volume are prevalent markers of late life dep...
Using cross-sectional structural magnetic resonance imaging (MRI) data from six cohorts originating ...
BACKGROUND: "Vascular depression" has recently been proposed. It is characterized by magnetic resona...
BACKGROUND: Late-life depression is a common and heterogeneous illness, associated with structural a...
BackgroundMajor depressive disorder (MDD) is a complex disorder that affects nearly 264 million peop...
BackgroundIncreasing understanding of the neural correlates of anxiety symptoms in late-life depress...
Background Late-life depression is a common and heterogeneous illness, associated with structural a...
Background: Neuroimaging studies have revealed structural and functional changes in brain regions as...
Major depressive disorder (MDD) is accompanied by atypical brain structure. This study first present...
Major depression is a prevalent disease among the elderly, significantly decreasing the quality of l...
Late-life depression (LLD) is a growing public and global health concern with diverse clinical manif...
Background: Reduced cortical thickness is a candidate biological marker of depression, although findi...
The brain disturbances that place a person at risk for developing depression are unknown. We imaged ...
OBJECTIVE Impaired mood regulation is a key deficit of major depressive disorder that is primarily m...
BACKGROUND: Late life depression is associated with volumetric reductions of gray matter and increas...
Background: Reduced cortical thickness and hippocampal volume are prevalent markers of late life dep...
Using cross-sectional structural magnetic resonance imaging (MRI) data from six cohorts originating ...
BACKGROUND: "Vascular depression" has recently been proposed. It is characterized by magnetic resona...
BACKGROUND: Late-life depression is a common and heterogeneous illness, associated with structural a...
BackgroundMajor depressive disorder (MDD) is a complex disorder that affects nearly 264 million peop...
BackgroundIncreasing understanding of the neural correlates of anxiety symptoms in late-life depress...
Background Late-life depression is a common and heterogeneous illness, associated with structural a...
Background: Neuroimaging studies have revealed structural and functional changes in brain regions as...
Major depressive disorder (MDD) is accompanied by atypical brain structure. This study first present...
Major depression is a prevalent disease among the elderly, significantly decreasing the quality of l...
Late-life depression (LLD) is a growing public and global health concern with diverse clinical manif...